Alert detail
LCD L38070: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies — CGS
What changed
New LCD to improve billing for myeloid malignancy testing.
Who’s affected: Clinical Laboratory billing teams · Effective: February 19, 2026
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 9 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.